Mode
Text Size
Log in / Sign up

rasagiline

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of rasagiline

13 trials tracked of rasagiline: 5 in phase 3 or 4.

13Trials tracked
5Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 3 Phase 3 2 Phase 2 5 Phase 1 2 Other / NA 1
  1. Phase 4 Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's Disease Completed
  2. Phase 4 Rasagiline for the Symptomatic Treatment of Fatigue in Parkinson's Disease Completed
  3. Phase 4 Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease Completed
  4. Phase 3 Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa in China Completed
  5. Phase 3 A Randomized Placebo Controlled Study to Show That Rasagiline May Slow Disease Progression for Parkinson's Disease Completed
  6. Phase 2 Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS) Completed
Show 7 more trials
  1. Phase 2 Trial of Safety and Efficacy of Rasagiline in Patients With Amyotrophic Lateral Sclerosis (ALS) Completed
  2. Phase 2 Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P) Completed
  3. Phase 2 Rasagiline Rescue in Alzheimer's Disease Clinical Trial Completed
  4. Phase 2 Image Parkinson's Disease Progression Study Completed
  5. Phase 1 Effect of Rasagiline on BIA 9-1067 Pharmacokinetics Completed
  6. Phase 1 Effect of BIA 9-1067 on Rasagiline Pharmacokinetics Completed
  7. N/A Rasagiline Tablets Special Drug Use-Results Survey "Survey on Long-term Safety" Completed

Showing the 13 most-cited and recently-updated of 13 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.